The global Rapid Acting Insulin Market is entering a new phase of steady and technology-driven growth. Valued at USD 7.71 billion in 2024, the market is projected to reach USD 11.77 billion by 2033, expanding at a compound annual growth rate (CAGR) of 4.81% between 2025 and 2033, according to Renub Research. This upward trajectory […]